HMOX1 and inflammatory bowel disease: Nrf2 exhibits anti-inflammatory, antioxidant, and anti-ferroptosis properties, and targeting the Nrf2/HO-1 pathway is an effective approach to attenuate ferroptosis in IBD [104].